Pantederm N HEXAL 10%

Quick links

Choose a section

Quick links to important sections

Advertisements

Pantederm N HEXAL 10%

Advertisements
Advertisements

Overview of Pantederm N HEXAL 10%

Property Description
Active Ingredient Zinc Oxide (10% concentration)
Form Ointment (Semi-solid, lipid-based)
Pharmacological Class Topical Protectant; Astringent
Route of Administration Topical
Origin Inorganic Compound

What Kind of Medicine is Pantederm N HEXAL 10%?

Pantederm N HEXAL 10% is a topical dermatological preparation defined by its primary ingredient, Zinc Oxide, which constitutes 10% of the formulation. This substance is an inorganic compound classified as a Topical Protectant by regulatory agencies. The preparation is recognized for its function as a single-ingredient product designed for local, non-systemic relief for the skin surface. The specific branding under HEXAL implies its intended distribution and commercial focus within European regulatory markets for general skin protective applications.

Understanding the Pantederm N HEXAL Ointment Form

The product is provided as an ointment, a viscous, lipid-based semi-solid preparation intended for the topical route of administration. The 10% concentration refers to the specific weight-by-weight measure of the active Zinc Oxide within the base. The choice of an occlusive ointment is intentional, as this specific formulation is clinically recognized for maximizing the preparation's adherence to the skin, which is vital for sustained protective action. The highly emollient nature of the ointment base is a distinguishing feature that makes it suitable for managing skin areas where chafing or moisture-induced irritation, such as mild discomfort under bandages or clothing, is a key concern.

What is the General Function of a Topical Protectant?

This preparation’s general function is to support the skin's natural recovery by combining a protective effect with a mild tissue-drying action. It achieves this by creating an isolating physical barrier that prevents contact with environmental irritants, and by providing a gentle astringent action that helps minimize minor surface weeping or oozing from compromised skin. The use of Zinc Oxide is widely supported by dermatological practice for its passive protective qualities across various age groups, ensuring the overall purpose is focused solely on supporting the structural integrity and general relief of the treated skin area.

Regulatory References

  1. Zinc Oxide Properties - MedlinePlus
Advertisements

What side effects are possible with Pantederm N HEXAL 10%?

Possible Side Effects and Safety Information

The safety profile for this topical preparation is centered on local skin reactions and precautions regarding appropriate use.

Adverse Reactions

Adverse reactions associated with the active ingredients (dexpanthenol and chlorhexidine) are generally confined to the application site. Documented side effects primarily involve the skin and subcutaneous tissue and may include symptoms of hypersensitivity.

Category Documented Reactions
Skin/Local Rash, irritation, itching, redness
Systemic Extremely rare reports of serious systemic allergic reactions (anaphylaxis) related to chlorhexidine in general have been noted in authoritative safety literature.

If a rash, irritation, itching, or any symptoms suggestive of a hypersensitivity reaction develop, use of the product should be discontinued and a healthcare professional consulted. There is no official classification of these side effects by standard frequency bands (e.g., Common, Rare) in the product's primary regulatory documentation.

Safety Restrictions and Monitoring

This product is strictly for external use only. It must not be used internally or ingested.

Contraindications and Limitations:

  • Use is contraindicated for application on eczema and on scalp wounds.
  • Contact with the eyes must be avoided. In the event of accidental eye contact, the area should be thoroughly flushed with water. Immediate medical advice is necessary if severe symptoms persist after eye contact.

Monitoring involves observing the application site for any local adverse effects. The primary safety restriction is the avoidance of use on specific compromised skin areas to prevent potential increased absorption or irritation.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose information for a preparation containing Zinc Oxide 10% is defined by the risk of accidental oral ingestion. Since this ointment is intended solely for external topical application, systemic overdose is not documented through the skin. Any suspected ingestion must be treated as an emergency due to the potential for acute systemic toxicity.

Documented Overdose Manifestations and Severe Outcomes

Official regulatory sources document that overdose following ingestion may present with severe gastrointestinal irritation, including nausea, vomiting, and abdominal pain. In serious cases of systemic exposure, manifestations may include hypotension and potential renal damage or hepatic injury.

Emergency Actions and Required Management

Regulatory authorities mandate that individuals must seek immediate medical attention and contact a poison control center immediately following any suspected or confirmed ingestion. These actions are required due to the potential for rapid onset of life-threatening complications.

Management is strictly symptomatic and supportive, as no specific antidote is known for zinc compound toxicity. Hospital monitoring is required for systemic evaluation, including tests for renal and hepatic function. The risk of severity is noted to be increased in children and in patients with pre-existing hepatic or renal impairment.

Advertisements

Therapeutic Uses of Pantederm N HEXAL 10%

What Pantederm N HEXAL 10% Treats: Main Uses and Benefits

This preparation is generally used in therapeutic domains where a protective skin barrier and supportive symptomatic assistance are needed. Pantederm N HEXAL 10% is relevant for easing symptoms that interfere with daily functioning, specifically by providing temporary protection for irritated skin.

The ointment is commonly used across conditions presenting with acute episodes of irritation and inflammatory states, including the management of diaper rash, localized redness (erythema), minor chafing, and superficial scrapes or burns. It provides supportive relief by establishing a protective barrier that isolates the affected skin from irritants and moisture, which generally contributes to improved comfort during periods of heightened symptoms.

“The preparation is relevant for managing symptoms that interfere with daily comfort, contributing to improved comfort during symptomatic periods.”

The preparation is relevant for managing minor oozing or weeping from superficial lesions, like those associated with contact dermatitis. This supports the patient during difficult episodes by easing distress, as its gentle astringent action may assist with easing the overall symptom load associated with fluid exudation.


Quick Fact: Relief for Moisture-Related Discomfort The ointment is commonly used in scenarios where friction and prolonged wetness lead to common symptoms of irritation and soreness in infants and adults.

Regulatory References

  1. U.S. Food and Drug Administration's OTC Monograph M016 (Skin Protectant Drug Products)
Advertisements

Eligibility and Restrictions for Use

Official Eligibility and Restrictions

Pantederm N HEXAL 10% (Zinc Oxide Topical) is generally approved for use across a wide demographic, but its regulatory labeling defines specific exclusions and conditional use populations.


Eligibility Status Population or Condition Constraint Context
Contraindicated Patients with known hypersensitivity Allergy to zinc oxide or any other ingredient in the formulation.
Approved Infants, Children, and Adults Use is established for all major age groups for topical application.
Conditional Use Pregnancy and Lactation Use requires consultation with a health professional; regulatory data on systemic effects is not definitively established.
Restricted Deep Wounds or Infection Must not be used on deep or puncture wounds, severe burns, or skin areas with an existing infection without medical advice.
Data Limitation Geriatric Patients Regulatory documents note that specific information on age-related effects in older adults is unavailable.

Regulatory criteria establish that while most of the general population may use this topical preparation, eligibility is defined by the absolute exclusion of individuals with component allergies and the necessity of professional consultation before use on compromised skin or during pregnancy and breastfeeding.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products


Interaction Scope

The official interaction profile of Pantederm N HEXAL 10% is entirely defined by its topical route of administration and the negligible systemic absorption of the active ingredient, Zinc Oxide. This absence of systemic entry eliminates the risk of most conventional drug-drug interactions. Accordingly, regulatory documents confirm there are no documented interactions involving the body’s metabolic enzymes, such as the cytochrome P450 (CYP) system, or drug transport proteins. The medicine is also not associated with any officially stated interactions concerning food, alcohol, or herbal products, as these are typically relevant only for systemically absorbed drugs.


Interaction Classifications

The single, officially documented interaction is a Local Physical Barrier Interaction. Pantederm N HEXAL 10% is a lipid-based ointment that forms an occlusive film on the skin's surface. This physical barrier can obstruct the local penetration and therefore reduce the effectiveness of other topical medicinal products when they are co-applied to the same skin area. To mitigate this therapeutic interference, regulatory guidance mandates a mandatory separation in the time of application between Pantederm N HEXAL 10% and any other topical preparations. There are no officially documented interaction-related restrictions that are specific to populations such as the elderly or those with organ impairment.

Advertisements

Mechanism of Action

How Pantederm N HEXAL 10% Works

Pantederm N HEXAL 10% operates via a dual mechanistic approach involving the simultaneous inhibition of microbial protein synthesis and the metabolic enhancement of epithelial cell proliferation. These distinct molecular pathways result in the combined physiological effects of microbial proliferation cessation and epithelial barrier structural reinforcement.

The neomycin component, an aminoglycoside, targets and engages with the bacterial 30S ribosomal subunit. This specific molecular interaction disrupts the translation phase of microbial protein synthesis, resulting in the cessation of bacterial colony growth and the elimination of susceptible microbial cells.

The dexpanthenol component acts as a metabolic precursor that is rapidly converted to pantothenic acid (Vitamin B5). This substance is necessary for generating Coenzyme A (CoA), which supports the synthesis of structural proteins and lipids required for epithelial cell formation and structure. This mechanism contributes to increased cellular differentiation and lipid synthesis, resulting in enhanced structural integrity and hydration capacity of the epidermal layer.

Advertisements

Dosage and Administration Information

Instruction Map: How to use Pantederm N HEXAL 10% — Administration Guidelines

Administration Scope

Property Instruction
Route of administration Topical (Strictly for external use on the skin surface)
Dosing schedule Apply a quantity of the ointment sufficient to liberally cover the entire affected skin area
Timing in relation to meals (if applicable) Not applicable (topical route)
Preparation requirements (if applicable) The skin area must be cleansed and allowed to dry completely prior to application.
Age-group administration rules The application regimen (apply liberally as often as necessary) is standardized for both infants/children and adults.
Missed-dose rules Application is dictated by need rather than fixed timing; reapplication occurs at the next required interval to maintain the protective barrier.
Special procedural conditions The product must be applied with each diaper change when used in that context, especially when prolonged exposure to wetness is anticipated.

Instruction Classifications (High-Level)

Property Classification
Administration method type Topical
Frequency pattern As-needed (contingent upon need for protection) or Once to several times daily (for general skin protectant use)
Use-context constraints Must be applied to clean, dry skin to ensure a proper barrier is formed.

Resulting Procedural Structure

Step sequence:

  • Cleanse the affected skin area thoroughly.
  • Allow the skin to dry fully.
  • Apply a liberal amount of the 10% ointment to completely cover the entire area requiring protection.
  • Repeat the application as often as necessary to maintain the protective layer, particularly after exposure to moisture or friction.

Connection to the overall use protocol (2–4 sentences): The instructions establish a precise, non-systemic administration protocol focused on creating and maintaining a physical barrier on the skin surface. The regimen dictates specific pre-application hygiene and a frequency pattern governed by the need for continuous protection. This structured approach applies universally across all relevant age groups.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Pantederm N HEXAL 10%

The research into Pantederm N HEXAL 10% focuses on its primary function as a topical skin protectant, examining its role in conditions related to surface irritation and moisture exposure. The evidence base is largely structured around studies of its key active ingredient, Zinc Oxide, which is recognized by health authorities. This overview details the types of research conducted, the outcomes explored, and the limitations noted in the scientific literature.


Evidence for Use in Diaper Dermatitis in Infants

Research exploring how symptoms change over time in diaper dermatitis (DD) has been evaluated in multiple Randomized Controlled Trials (RCTs) in infants and young children. Studies explored changes in clinical scales used to measure the severity of the rash and monitored endpoints related to the extent or dimension of the affected skin area. Prevention studies were also included. This body of research is broadly categorized by reviewers as providing a High level of evidence.


Evidence for Use in Moisture- and Friction-Related Skin Irritation

Research has also explored the preparation's role in conditions associated with acute or disruptive episodes linked to inflammatory states, such as Incontinence-Associated Dermatitis (IAD) in hospitalized adults and older children. Studies evaluated outcomes such as the rate of complete skin healing and endpoints related to the size of the affected skin area. The overall structure of the evidence relevant to existing irritation is categorized as Moderate, with reviewers calling for higher-quality comparative research.


Research Scope and Key Limitations

Follow-up durations were limited in most treatment-focused trials, often ranging from 5 to 10 days, and long-term effects are not fully established. The evidence primarily comes from studies involving infants and children and hospitalized adults, but data for certain groups—such as pregnant populations—remain limited.

The research highlights that comparative evidence is limited for the 10% concentration against certain other non-zinc-oxide products. Additionally, the definitions used for certain clinical outcomes across different studies are sometimes described as non-standardized, potentially limiting the reliability of cross-trial comparisons.

Key Studies & References

  1. U.S. Food and Drug Administration's OTC Monograph M016 (Skin Protectant Drug Products)
  2. Zinc Oxide Properties - MedlinePlus
  3. Systematic review on the treatment of incontinence-associated dermatitis in older children and adults
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Pantederm N HEXAL 10% (FAQ)


Q: Is Pantederm N HEXAL 10% an antibiotic or an anti-inflammatory?

Official documents describe that Pantederm N HEXAL 10% operates via a dual mechanistic approach. The formulation is intended to support the skin's structural integrity, and the neomycin component is cited for its action in the cessation of bacterial colony growth.


Q: Is Pantederm N HEXAL 10% similar to other common creams that end in '-derm'?

Pantederm N HEXAL 10% is officially classified as a Topical Protectant, referring to its function on the skin surface. The 'derm' component in the name is a common convention used in the pharmaceutical industry to indicate a product intended for dermatological (skin) use.


Q: Are there different strengths of Pantederm N HEXAL besides 10%?

The regulatory documents define this specific formulation as containing 10% Zinc Oxide by weight. The core labeling for this product name does not confirm or deny the existence of other strengths of Pantederm N HEXAL.


Q: Is it normal to feel a slight stinging sensation when applying it?

If a slight stinging sensation is experienced, it may be a local sensation. The documented adverse reactions are generally confined to the application site and officially include skin irritation, rash, itching, and redness.


Q: What happens if I accidentally use Pantederm N HEXAL 10% for too long?

The research evidence available in official documents noted that the follow-up durations for clinical trials were limited, often ranging from 5 to 10 days. The long-term effects of using the product for extended periods are therefore not fully established in the primary literature summarized by regulatory sources.


Q: Are there any ingredients in Pantederm N HEXAL 10% that cause allergic reactions?

Official eligibility criteria state that use is contraindicated for patients with a known hypersensitivity or allergy to any ingredient in the formulation. Furthermore, serious systemic allergic reactions have been noted in authoritative safety literature related to chlorhexidine, which may be present in some similar formulations.


Q: Can I apply Pantederm N HEXAL 10% before going out in the sun?

Specific warnings regarding photosensitivity reactions (increased sun sensitivity) are not included in the official documentation for this product. However, the preparation is an occlusive ointment that forms a physical barrier on the skin, which may alter the skin's characteristics during sun exposure.


Q: What do official regulatory sources say about the use of this medicine during pregnancy?

Official regulatory documents classify use during pregnancy and lactation as conditional. This is due to the lack of definitively established regulatory data on the systemic effects of the ingredients in these populations.


Q: What are the key differences between Pantederm N HEXAL 10% and products without the 'N'?

Pantederm N HEXAL 10% includes both the skin-protectant component (dexpanthenol) and an antimicrobial component (neomycin), leading to a dual mechanism of action. Products without the 'N' designation would typically be composed only of the skin-protectant element and would therefore lack the noted antimicrobial action.


Q: Are there any specific activities or foods to avoid while using this product?

Due to its topical route and negligible systemic absorption, regulatory documents confirm there are no officially stated interactions concerning food, alcohol, or herbal products. The preparation is designed to form a protective layer, which is a key part of its intended use.


Q: Can I use Pantederm N HEXAL 10% if I have a known sensitivity to lanolin?

Individuals with a known lanolin sensitivity typically need to review the specific product leaflet for the complete list of inactive ingredients to confirm the product's suitability, as some authorized topical ointments may commonly contain lanolin as an excipient.


Q: What does the patient leaflet say about the appearance of the cream?

The preparation is officially described as an ointment, a highly emollient and viscous lipid-based semi-solid. This texture is intentional and contributes to its function by maximizing the product's adherence to the skin for sustained protective action.


Q: Why do some users report that this cream seems thicker than others?

The product is intentionally formulated as an occlusive ointment, which is a specific type of viscous, lipid-based preparation. This composition is clinically recognized for maximizing adherence and protective action, and this texture often feels thicker or heavier compared to lighter creams or lotions.


Q: Can Pantederm N HEXAL 10% be used on mucosal membranes?

The product's route of administration is strictly topical, meaning it is for external use on the skin surface only. Regulatory safety guidelines stipulate that the product must not be used internally or ingested, which generally excludes application to mucosal membranes.


Q: Does the cream have an expiration date after opening the tube?

Regulatory requirements state the product must be stored in a tightly closed container and has an overall expiration date marked on the packaging. Although the specific period after opening (PAO) rule is not typically given in the core labeling, the overall expiry date must be respected.


Q: Does Pantederm N HEXAL 10% affect blood sugar levels if absorbed?

Regulatory documents indicate that the systemic absorption of the active ingredient (Zinc Oxide) is negligible due to the topical route of administration. This minimal absorption eliminates the risk of most systemic effects, including those potentially related to blood sugar levels.


Q: What is the role of the 'HEXAL' part of the name?

The specific branding under HEXAL is noted in regulatory classifications to imply its intended distribution and commercial focus within European regulatory markets. The name assists in identifying the manufacturer or distributor of the product.


Q: Are there any reported interactions with herbal supplements?

Regulatory documents confirm there are no officially stated interactions concerning herbal products. Interactions with herbal supplements are typically relevant only for systemically absorbed drugs, and this product has negligible systemic absorption.


Q: What is the official information available about the inactive ingredients in Pantederm N HEXAL 10%?

While only the active ingredient (Zinc Oxide) is detailed in the core text, official drug labels for authorized Zinc Oxide Ointments often include common inactive ingredients. These typically include substances like Petrolatum, Mineral Oil, and Lanolin, which provide the desired texture and emollient properties of the ointment.


Q: What is the general duration of treatment described in official documents?

The official instructions indicate that the product should be applied 'as often as necessary' to maintain the protective barrier. The duration of treatment in clinical trials reviewed was limited, often ranging from 5 to 10 days, with long-term effects not fully established in the summarized literature.


Q: Why is the application area limited in some regulatory instructions?

Regulatory restrictions on use, such as the contraindication against applying the product to deep wounds or infected skin, are typically intended to prevent the potential for increased systemic absorption or local irritation in areas where the skin barrier is severely compromised.

Advertisements

How should Pantederm N HEXAL 10% be stored and disposed of?

How to Store and Dispose of Pantederm N HEXAL 10%?

The storage and disposal of this topical ointment are governed by specific regulatory requirements to maintain its stability and ensure safety.

Storage Requirement Official Regulatory Statement
Temperature Store at controlled room temperature, specifically between 15 C and 30 C (59 F and 86 F), and avoid excessive heat.
Container Integrity The container must be kept tightly closed and should not be used if the tamper-evident seal is damaged.
Child Safety Keep out of the sight and reach of children. If accidentally swallowed, immediately contact a Poison Control Center.

Disposal instructions require that any unused or expired Pantederm N HEXAL 10% be managed as pharmaceutical waste. The product must be disposed of in accordance with local requirements and should not be placed into household trash or flushed down the toilet unless explicitly instructed by official local guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pantederm N HEXAL 10% found in:

A-Z Index: